Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Before I do, I want to send some quick gratitude to my paid subscribers
According to CMS guidance, physicians who prescribe GLP-1 drugs under the Bridge must attest to the patient's clinical eligibility at the time therapy was first initiated even if that initial prescription was written before July 1, 2026
We highlight ongoing clinical trials for GLP-1 receptor therapies in cancer patients, and offer considerations for preclinical studies, including perspectives on the timing and duration of GLP-1 receptor agonist treatment, concurrent use of standard anticancer therapies, and interpretation of models of cancer risk versus progression
In retrospect, the article can be seen as one of the foundation stones of what is now often called the ascorbateglutathione pathway, or FoyerHalliwellAsada pathway (Foyer and Kunert 2024)
Patients should be educated on recognising hypoglycaemia symptoms and carrying fast-acting glucose sources at all times
.webp)
